CIK 0001655759 · Accelerated filer
ARVINAS, INC.
Sign in to watch- Ticker
- ARVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472566120
- Phone
- 203-535-1456
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, NEW HAVEN, CT, 06511
- Former names
- ARVINAS INC., ARVINAS HOLDING COMPANY, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,475
- in 1 filing, $1K under 10b5-1 plans
Net −$1,475. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-24 | Taylor Ian President, R&D | Sale | −1,664 | $16.55 | $28K | 159,121 |
| 2025-02-24 | Houston John G President and CEO | Sale | −26,184 | $16.75 | $439K | 1,162,634 |
| 2025-02-24 | Houston John G President and CEO | Sale | −5,154 | $16.55 | $85K | 1,157,480 |
| 2025-02-13 | Loomis David K Chief Accounting Officer | Grant or award | +10,584 | 18,624 | ||
| 2025-02-13 | Loomis David K Chief Accounting Officer | Grant or award · Stock Option (right to buy) | +16,176 | 16,176 | ||
| 2025-02-13 | Saik Andrew Chief Financial Officer | Grant or award | +49,092 | 110,501 | ||
| 2025-02-13 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (right to buy) | +74,960 | 74,960 | ||
| 2025-02-13 | Taylor Ian Chief Scientific Officer | Grant or award | +20,619 | 168,141 | ||
| 2025-02-13 | Taylor Ian Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +31,483 | 31,483 | ||
| 2025-02-13 | Berkowitz Noah Chief Medical Officer | Grant or award | +55,229 | 118,681 | ||
| 2025-02-13 | Berkowitz Noah Chief Medical Officer | Grant or award · Stock Option (right to buy) | +84,330 | 84,330 | ||
| 2025-02-13 | Cacace Angela M Chief Scientific Officer | Grant or award | +49,092 | 100,944 | ||
| 2025-02-13 | Cacace Angela M Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +74,960 | 74,960 | ||
| 2025-02-13 | Houston John G President and CEO | Grant or award | +152,000 | 1,188,681 | ||
| 2025-02-13 | Houston John G President and CEO | Grant or award · Stock Option (right to buy) | +232,000 | 232,000 | ||
| 2024-11-07 | Loomis David K Chief Accounting Officer | Sale | −231 | $27.69 | $6K | 8,040 |
| 2024-06-24 | Saik Andrew Chief Financial Officer | Grant or award | +61,409 | 61,409 | ||
| 2024-06-24 | Saik Andrew Chief Financial Officer | Grant or award · Stock Option (right to buy) | +94,418 | 94,418 | ||
| 2024-06-17 | Cacace Angela M Chief Scientific Officer | Grant or award | +15,995 | 51,852 | ||
| 2024-06-17 | Cacace Angela M Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +24,632 | 24,632 |
Page 5 of 10 · 184 trades